ONCC Practice Tests (OCN - Symptom
Management and Palliative Care) – Q and
A
Which of the following is a dose-limiting toxicity of irinotecan?
Diarrhea
Miosis
Vomiting
Alopecia - -Diarrhea
Answer: Diarrhea is the dose-limiting toxicity for irinotecan.
Reference: Polovich, M., Olsen, M., & LeFebvre, K. (Eds.). (2014).
Chemotherapy and biotherapy guidelines and recommendations for practice
(4th ed.). Pittsburgh, PA: Oncology Nursing Society, p. 44(t).
-Administration of filgrastim maintains the dose intensity of a treatment
regimen by reducing the:
occurrence of febrile neutropenia.
need for leucovorin rescue.
occurrence of nausea and vomiting.
risk of cardiotoxicity. - -occurrence of febrile neutropenia.
Answer: Filgrastim is used to reduce the risk of febrile neutropenia.
Reference: Eggert, J. (Ed.). (2017). Cancer basics (2nd ed.). Pittsburgh, PA:
Oncology Nursing Society, pp. 227-228.
-One year after receiving total body irradiation for a hematopoietic stem cell
transplant, a patient reports increasingly dim vision and ocular sensitivity.
The nurse suspects which late effect related to treatment?
Answer: Patients who receive total body irradiation are at greater risk for the
development of cataracts.
, Reference: Yarbro, C.H., Wujcik, D., & Gobel, B.H. (Eds.). (2018). Cancer
nursing: Principles and practice (8th ed.). Burlington, MA: Jones and Bartlett,
p. 602.
-A 78-year-old patient with prostate cancer and cardiovascular disease is
taking naproxen twice a day and a daily dose of acetylsalicylic acid. The
nurse instructs the patient to:
speak with the physician about adding a cytoprotectant.
space the medications at least one hour apart.
take the medications on an empty stomach.
expect an increase in swelling of the extremities during the evening. - -
speak with the physician about adding a cytoprotectant.
Answer: Patients receiving cyclooxygenase-1 inhibitors who are high risk
based on existing cardiac disease should consider the addition of a
cytoprotectant.
Reference: Yarbro, C.H., Wujcik, D., & Gobel, B.H. (Eds.). (2018). Cancer
nursing: Principles and practice (8th ed.). Burlington, MA: Jones and Bartlett,
p. 801(t).
-A patient receiving a fluorouracil-based combination chemotherapy
regimen is employed as a landscaper. The nurse teaches the patient about
the risk of:
Answer: Photosensitivity is a side effect of fluorouracil.
Reference: Polovich, M., Olsen, M., & LeFebvre, K. (Eds.). (2014).
Chemotherapy and biotherapy guidelines and recommendations for practice
(4th ed.). Pittsburgh, PA: Oncology Nursing Society, p. 34(t).
-A patient who reports nausea four days after receiving chemotherapy is
experiencing which type of chemotherapy-induced nausea?
Delayed
Acute
Refractory
Breakthrough - -Delayed
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Victorious23. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for £9.48. You're not tied to anything after your purchase.